The National Lipid Association remains focused on enhancing the practice of lipid management in clinical medicine, with guideline education and participation as a critical part of our efforts. NLA represents the intellectual leadership on the blood cholesterol and triglyceride space. NLA leaders and members are routinely present in the development of cholesterol guidelines and expert consensus pathways, including Kim K. Birtcher, PharmD, MS, FNLA, Roger S. Blumenthal, MD, FNLA, Lynne T.

Article By:

Carl E. Orringer, MD, FNLA

President, National Lipid Association, 2015-2016

Joseph J. Saseen, PharmD, CLS, FNLA

President, National Lipid Association, 2020-2022

0
No votes yet

The Southeast Lipid Association originated as an extension of an annual southern academic forum (Southeastern Lipid Conference) based on the science of cholesterol metabolism. A group of well-known academic physicians convened in 1997 to discuss the potential of starting a lipid association. The founding group of physicians had the vision to form an association that would become focused on the practical application and integration of science into clinical lipidology practice.

Article By:

Penny M. Kris-Etherton, PhD, RD, FNLA

President, National Lipid Association, 2011-2012

 

Anne C. Goldberg, MD, FNLA

President, National Lipid Association, 2007-2008

Joyce L. Ross, MSN, CRNP, CLS, FNLA

President, National Lipid Association, 2016-2017

Vera A. Bittner, MD, MSPH, FNLA

President, National Lipid Association, 2009-2010

0
No votes yet

In 1987, to combat the number one killer of American people, cardiovascular disease, the National Cholesterol Education Program (NCEP) released Adult Treatment Panel Guidelines to coincide with the release of the first FDA-approved statin, lovastatin. By 1996, the goal was clear: reduce LDL-C to less than 100 mg/dL in all people with known coronary disease or major risk factors such as diabetes mellitus.

Article By:

John R. Guyton, MD, FNLA

President, National Lipid Association, 2004-2005

W. Virgil Brown, MD, FNLA

President, National Lipid Association, 2002-2004

0
No votes yet

The lipid hypothesis states that elevated plasma cholesterol, more specifically, LDL cholesterol, has a causal role in the development of coronary heart disease and other cardiovascular diseases. This hypothesis has been debated for over 150 years. Cholesterol was first discovered in bile and in the gallstones by Poulletier de la Salle in 1769 and rediscovered by Michel Eugene Chevreul in 1815. The latter coined the name “cholesterine” which was shown to be present in bilestones.

Article By:

Antonio M. Gotto Jr., MD, DPhil, FNLA

President, National Lipid Association, 2019-2020

0
No votes yet
Last Updated: Tuesday, 24-May-2022 12:30:00 EDT

Regeneron Pharmaceuticals, Inc. announced positive results from a Phase 3 trial evaluating Evkeeza® (evinacumab) in children aged 5 to 11 with homozygous familial hypercholesterolemia (HoFH). The trial met its primary endpoint, showing children who added investigational evinacumab to other lipid-lowering therapies reduced their low-density lipoprotein-cholesterol (LDL-C) by an average of 48% at week 24 of the study. Anne C.

Last Updated: Monday, 11-Apr-2022 18:30:00 EDT

Kowa Research Institute, Inc. has announced the decision to not continue its Phase 3 PROMINENT study. Read the press release. Kowa has indicated that full data will be shared at a future conference. 

Last Updated: Thursday, 31-Mar-2022 21:15:00 EDT

Be sure to read the latest JCL Roundtable featuring Lauren Williams, RDN, Lynne T. Braun, PhD, CNP, FNLA, Joseph J. Saseen, PharmD, FNLA, and John R. Guyton, MD, FNLA discussing the importance of the lipidology team. 

Abstract

Resource # 21 Reflection

Thank you for participating in the 21 Day Challenge. Below please find your opportunity to reflect on today's activity. Note: Chapter and Reflection are the only mandatory fields, though the NLA hopes to collect participant demographic data for improvement of DEI within our organization.

 
1 Start 2 Complete

This page was last updated: Mar 13, 2022

Resource # 20 Reflection

Thank you for participating in the 21 Day Challenge. Below please find your opportunity to reflect on today's activity. Note: Chapter and Reflection are the only mandatory fields, though the NLA hopes to collect participant demographic data for improvement of DEI within our organization.

 
1 Start 2 Complete

This page was last updated: Mar 12, 2022

Resource # 19 Reflection

Thank you for participating in the 21 Day Challenge. Below please find your opportunity to reflect on today's activity. Note: Chapter and Reflection are the only mandatory fields, though the NLA hopes to collect participant demographic data for improvement of DEI within our organization.

 
1 Start 2 Complete

This page was last updated: Mar 12, 2022